Eshlsg consultation-results-october2013

REGISTER OF PAYMENTS – CONSULTATION SURVEY

Prepared for: Ethical Standards in Health & Life Sciences Group

By: Jane Fligelstone – The Consortium and Nicky Taylor – Taylor McKenzie


• To assess reactions of Individuals, Commercial and Healthcare Organisations

towards the scheme outlined in the Register of Payments Consultation

document

• And in particular, issues of:

• Transparency and public declaration of payments, in a publicly searchable database

• Who should host the scheme and what role HCPs should play

• Whether payments from all types of Life Science companies should be included

• To understand the potential impact that public disclosure of payments could

have on Individuals’ collaboration with Commercial Organisations

Objectives of the Survey

NB: This consultation has been funded by the ABPI.


Methodology

Quantitative

Online Survey

1055 responses Including 2 not completed online – BMA and RCGP

Timings

Survey live

28th January – July 5th 2013


Overall Sample Total Response 1056

Individuals (40+ mentions) 981

• Secondary Care Doctor Excluding Psychiatrists 500

• Psychiatrists 185

• GPs 75

• Pharmaceutical Company Employees 63

• Doctors in Commercial Organisation 47

• Other Individuals 111

Commercial Companies 64

Healthcare Organisations (large) 8*

Healthcare Organisations (small) 3

* Includes two

questionnaires not done

online, not included in

quantitative analysis


Sample of Healthcare Organisations Healthcare Organisations (large) 6

• British Medical Association *

• Royal Society of General Practitioners *

• Royal College of Physicians

• British Pharmacological Society

• Guild of Healthcare Pharmacists

• College of Optometrists

Private Healthcare Organisations (large) 2

• BUPA Health and Wellbeing

• AXA PPP Healthcare

* Includes two

questionnaires not done

online, not included in

quantitative analysis


Sample of Healthcare Organisations

Healthcare Organisations (small) 2

• Bedfordshire Clinical Commissioning Group

• Heathway Medical Centre

Private Healthcare Organisations (small) 1

• HSC Innovations


Other Individuals in Sample

Individuals - not already shown:

• Allied Health Professional 7

• Nurse 3

• Pharmacist 2

• Medical Devices / Diagnostics Company Employee 11

• Healthcare Manager 2

‘Other’ Individuals (not coded):

86

• Academic / Research in Medicine

• Retired

• Consultant in Pharmaceutical Sector


Sectors of Commercial Organisations

47%

31%

8% 14%

Commercial Organisations

Devices Pharmaceutical Bio-Pharma Other

What sector does your organisation/company belong to? N=64


Sectors of Healthcare Organisations

Large Healthcare Organisation - 6

Small Healthcare Organisation - 2

Large Private Healthcare Organisation – 2

Small Private Healthcare Organisation - 1


Membership of Individuals in Sample

9%

12%

16%

20%

56%

59%

0% 20% 40% 60%

RCGP

Faculty of Pharmaceutical Medicine

The Royal Society of Medicine

Royal College of Psychiatrists

Royal College of Physicians

BMA

Individual membership (top 6 organisations)

Base: 955 Individuals


• Statistical analysis has been conducted across each respondent type:

• Individuals, Commercial Companies and Healthcare Organisations

• Positions of Individuals (HCP, Company employee etc.)

• Whether HCPs work in NHS or private practice

• Membership of different organisations

• Sector of company

• Comments have been added to slides where statistically significant

differences were evident at a 95% level of confidence

Statistical Analysis

Results REGISTER OF PAYMENTS – CONSULTATION SURVEY


CHALLENGES

FACING PSME

Issue of Transparency

and Public Declaration

Single, Searchable Database

Host for System

HCP Involvement

Whether applicable to

all Life Science

Companies

Effect on Collaboration

Scope of Consultation

Should payments from

commercial organisations to

individually named health care

professionals be transparent?

89% 3% 7% Total


Transparency of Payments Almost universal agreement that payments should be transparent

Q1: Do you agree or disagree with the principle that payments from commercial organisations to individually named health care professionals should be transparent? Base: Total sample – 1054

Agree/strongly Neutral/Don’t know

Disagree/strongly

No difference in views of different respondent type

BMA and RCGP agree

Should payments from

commercial organisations to

individually named health care

professionals be publicly

declared?

77% 9% 15% Total


Public Declaration Widespread agreement that payments should be publicly declared

Q2: Do you agree or disagree with the principle that payments from commercial organisations to individually named health care professionals should be publicly declared ? Base: Total sample – 1054


Disagree/strongly


BMA and RCGP agree

Should system of disclosure take

form of single, publicly

searchable, central database?

79% 17% 4% Total


Single, Public Database Widespread agreement that disclosure should involve central, public database

Q3: Do you agree or disagree that a system of disclosure of payments should take the form of a single, publicly searchable, central database? Base: Those who strongly/agree or neither agree nor disagree that payments should be publicly declared (Q3) – 888


Disagree/strongly


Those in the Faculty of Pharmaceutical Medicine statistically less likely to

agree (71%) vs. those in BMA (81%)

BMA and RCGP agree

Who should host any system for

declaring payments?

9%

40%

16%

16%

40%

36%

12%

6%

15%

16%

35%

39%

0% 10% 20% 30% 40% 50%

Don't know

Trade Body•

Government

NHS

Professional Body

Regulator


Host for System of Disclosure Mixed views on best way of hosting the system

Q4: Who do you think should host any system for declaring payments? Base: Those who strongly/agree that there should be a single, publicly searchable database (Q4) - Individuals – 651; Commercial Companies - 45

Individuals Commercial Companies

GMC recommended as

regulator by RCGP

Should HCPs play a role in

disclosure of payments?

48%

66%

76%

78%

82%

77%

27%

15%

14%

14%

11%

13%

24%

20%

11%

9%

8%

10%

Academy MRC

RCPE

RCP

BMA

RCGP

Total


HCP involvement Members of most HCP organisations are in favour; the Academy of MRC are less

positive

Q5: Do you agree or disagree that individual health care professionals should play a role in the disclosure of payments received from commercial organisations (e.g. submitting information or validating the information submitted by others), alongside the submission of the same information by industry? Base: Total - 1054


Disagree/strongly

(N=1054)

(N=87)

(N=561)

(N=61)

(N=538)

(N=29)

Those in the Academy and RCPE statistically less likely to agree vs. those in BMA, RCP and RCGP BMA and RCGP agree

Should disclosure apply to all

types of commercial life sciences

organisations?

90% 4% 5% Total


Disclosure for all Life Sciences? Universal agreement that all types of company should be involved

Q6: Do you agree or disagree that disclosure of payments to health care professionals should apply to all types of commercial life sciences organisations (e.g. devices, diagnostics and bio-pharmaceutical industry) and not only the pharmaceutical industry? Base: Total - 1054


Disagree/strongly

No difference in views of different respondent type or those in different sectors

RCGP believes there should be a

definitive list of types of companies to

which disclosure applies


Impact of Public Disclosure on Future Collaboration with Commercial Organisations Majority consider that there would be little detrimental effect

8%

70%

14%

8% Would be more likely to collaborate

Would have no effect on mycollaboration

Would be less likely to collaborate

Don't know •

Q8: What impact would the public disclosure of payments have on your relationship with commercial organisations? Base: All individuals - 964

Little difference according to respondent

type or level of current collaboration;

Psychiatrists tend to consider they would

be ‘more likely’ to collaborate (given

public disclosure of payments) than

Secondary Care doctors (12% vs. 6%)

Effect of public disclosure of payments on relationship with commercial organisations


Public Disclosure of Payments could reduce collaboration for 1 in 6 who currently

take part in paid activities

Current participation in paid

activities with commercial

organisations

14%

7%

4%

61%

73%

72%

9%

16%

16%

15%

5%

8% Currently participate

Have participated in the past

Have never participated

More likely Will have no effect

Less likely Don’t know

(N=264)

(N=465)

(N=236)

Effect of public disclosure on relationship with commercial

organisations – willingness to collaborate in paid activities:

Q7: How would you describe your current level of collaboration with commercial organisations?; Q8: What impact would the public disclosure of payments have on your relationship with commercial organisations? Base: All individuals - 964

Health & Medicine

Eshlsg consultation-results-october2013